BELITE BIO INC - AMERICAN DEPOSITARY SHARES
58.80
05-February-25 13:06:54
15 minutes delayed
Stocks
+0.74
+1.27%
Today's range
57.42 - 58.84
ISIN
N/A
Source
NASDAQ
-
Belite Bio Announces $25 Million Registered Direct Offering
25 Apr 2024 19:15:29 By Nasdaq GlobeNewswire
-
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
22 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
11 Mar 2024 22:28:39 By Nasdaq GlobeNewswire
-
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
11 Mar 2024 21:27:47 By Nasdaq GlobeNewswire
-
06 Mar 2024 08:00:01 By Nasdaq GlobeNewswire
-
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
04 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
07 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
30 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio to Participate in the BTIG Ophthalmology Day
20 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
13 Nov 2023 20:15:47 By Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
07 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
06 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
27 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
08 Aug 2023 22:17:28 By Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
04 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
27 Jul 2023 17:00:00 By Nasdaq GlobeNewswire
-
30 May 2023 20:49:26 By Nasdaq GlobeNewswire
-
30 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results
10 May 2023 19:58:59 By Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
10 May 2023 15:33:22 By Nasdaq GlobeNewswire